NMRA vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

NMRA

38.0
AI Score
VS
JBIO Wins

JBIO

55.4
AI Score

Investment Advisor Scores

NMRA

38score
Recommendation
SELL

JBIO

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NMRA JBIO Winner
Net Income -96.54M -96.13M JBIO
Operating Income -95.05M -102.36M NMRA
ROE -216.9% -21.9% JBIO
ROA -77.1% -20.4% JBIO
Total Assets 125.25M 472.11M JBIO
Cash 116.83M 107.25M NMRA
Current Ratio 4.50 14.93 JBIO
Free Cash Flow -85.95M -67.93M JBIO

Relative Price Performance (Last 90 Days)

NMRA 1M: -63.8% · 3M: -70.4% JBIO 1M: -34.0% · 3M: -33.7%

Current Technical Phase

NMRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.0%), weak momentum, RSI 18

RSI (14): 18.0 · Price: $0.50

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 24

RSI (14): 24.2 · Price: $14.12

Fundamentals Snapshot

Metric NMRA JBIO
Market Cap — —
Forward P/E -0.8 -5.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.08 -1.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.